Cargando…
Potential Limitations in the Clinical Adoption of 3-GEP Pigmented Lesion Assay for Melanoma Triage by Dermatologists and Advanced Practice Practitioners
Background A pigmented lesion assay (PLA) is used to non-invasively detect the presence of three genes associated with melanoma (LINC00518, PRAME, and TERT) using adhesive patch testing and has the potential to reduce unnecessary biopsies. However, few studies have evaluated the clinical applicabili...
Autores principales: | Ludzik, Joanna, Lee, Claudia, Witkowski, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792410/ https://www.ncbi.nlm.nih.gov/pubmed/36579219 http://dx.doi.org/10.7759/cureus.31914 |
Ejemplares similares
-
Augmenting pigmented lesion assay results with the three‐point dermoscopy checklist to improve pigmented lesion triage
por: Ludzik, Joanna, et al.
Publicado: (2022) -
Dermoscopic features associated with 3‐GEP PLA: LINC00518, PRAME, and TERT expression in suspicious pigmented lesions
por: Ludzik, Joanna, et al.
Publicado: (2023) -
Professor Rona MacKie, Scottish dermatologist and melanoma authority()
por: Daunton, A., et al.
Publicado: (2015) -
The Influence of Modern Social Media on Dermatologist Selection by Patients
por: Albeshri, Mohammed, et al.
Publicado: (2020) -
Pigmented Basal Cell Carcinoma Masquerading as a Melanoma
por: Abudu, Boya, et al.
Publicado: (2019)